Background & Aims:
The surface epithelium of the colon is being replaced constantly with cells derived from the stem cells of the crypt. Although the location of the stem cells is known, there are no markers for these cells. This study tested the hypothesis that colonic stem cells might be isolated and cultured on the basis of specific integrin expression patterns in normal human colonic epithelium. Methods: Integrin expression in normal human colonic mucosa was determined by using indirect immunofluorescence. Crypt cells were then isolated as single cells from normal colon tissues and the expression pattern of integrins was analyzed by flow cytometry. Based on the specific expression of integrin ␤1 in colonic crypts, the cells were sorted by using a flow cytometer, and colony assays in soft agar were performed to evaluate the clonogenicity of the sorted cells. Results: By immunofluorescence, the cells located in the lower one third of crypts expressed higher levels of ␤1-integrin than the cells in the remainder of the crypt. When isolated crypt cells were stained with the ␤1-integrin antibody and examined in a flow cytometer, there were 2 peaks of fluorescence. Sorting of crypt cells based on staining with anti-␤1 integrin antibody produced a cell population with a significantly enhanced ability to form colonies. Conclusions: ␤1-integrin is a candidate surface marker for the proliferative zone of the human colonic crypt. Our in vitro culture system for the clonal growth of a single colonic crypt cell suspension could facilitate the identification of other candidate stem cell markers.
T he colonic epithelium is a continuously replicating tissue, with the crypt cells moving toward the lumen of the colon as they mature. 1, 2 Because of this continuous upward migration, the location of a cell within the migratory stream indicates its stage in the process of maturation, and the colonic epithelium therefore represents an attractive system for the study of mechanisms involved in the determination of the cell state. It has been suggested that the cells responsible for this replacement are stem cells located near the base of a colonic crypt. The existence of stem cells in the colon has been shown indirectly by anatomic studies and mosaic in vivo lineage-marking experiments. 2, 3 Although it is possible to monitor the frequency of particular events such as DNA synthesis, mitosis, and apoptosis along the axis of each crypt, stem cell biology in the colonic epithelium is poorly understood because no distinct markers for stem cells exist so far.
The ideal system for identifying these stem cells would be an in vitro culture system in which single cells can be grown as clones and induced to differentiate along specific lineages. Although this has been achieved in the hematopoietic system, 4, 5 in which a culture method was devised for the bone marrow precursor cells, such a system has not been possible for the intestinal mucosa because of the difficulty of maintaining these cells in culture in vitro until recently. We have established a novel method for the clonal growth of single cells derived from normal colonic epithelium (a clonogenic assay). 6 This method appears to possess great potential for identifying colonic stem cells because it enables us to obtain viable single-cell suspensions from colonic crypts isolated from normal colonic mucosa and to grow these cells in soft agar to evaluate their clonogenic potential. 6 The colonic epithelium lies on a thin and continuous sheet of basement membrane and specialized extracellular matrix (ECM). It is now recognized that the basement membrane composition defines the necessary microenvironment required for multiple cellular functions during development and at maturity such as adhesion, proliferation, migration, and cell survival. 7 These functions are mediated themselves by various cell receptors, many of which are members of the integrin superfamily. Integrins are transmembrane heterodimeric glycoproteins composed of an ␣ and a ␤ subunit. At least 17 ␣ and 8 ␤ subunits have been identified to date, and these can give rise to 22 different integrin receptors. Recently, several investigators have reported that certain integrins might be stem cell markers in certain tissues, including skin 8 -10 and testis. 11 Because it appears that stem cells of different tissues show certain similarities in biologic behavior, 12 we hypothesized that all stem cells might share similar molecular properties even though the cell types or number of lineages produced during differentiation of daughter cells might be quite variable.
In this study, we describe the localization of integrins in the colonic epithelium and use of our clonogenic assay to test the hypothesis that colonic stem cells, like those of other self-renewing systems, express specific integrins associated with attachment to basement membranes.
Materials and Methods

Human Colon Tissues
Human colon tissues were obtained from surgical specimens removed as treatment for colon carcinoma under a protocol approved by the Vanderbilt Committee for the Protection of Human Subjects, Institutional Review Board. A piece of morphologically normal colonic tissue was removed by a pathologist from a site at least 15 cm proximal from the lesion and transferred to the laboratory in phosphate-buffered saline (PBS). All tissues used in this study were obtained from tumors in the distal colon. A 0.5 ϫ 0.5-cm piece was used to make the cryosections for immunofluorescence and another 1 ϫ 5-cm piece was used to isolate crypts. All tissues were processed within 1 hour after the surgery.
Antibodies
Seven ␣-integrin and 5 ␤-integrin antibodies were purchased from Chemicon International Inc. (Temecula, CA). ␣-integrin antibodies were mouse anti-human ␣1 (clone FB12), ␣2 (clone P1E6), ␣3 (clone P1B5), ␣4 (clone P1H4), ␣5 (clone P1D6), ␣V (clone P3G8), and rat anti-human ␣6 (clone NKI-G0H3) monoclonal antibodies. ␤-integrin antibodies were mouse anti-human ␤1 (clone P4G11), ␤2 (clone P4H9), ␤3 (clone 25E11), ␤4 (clone ASC-9) monoclonal antibodies, and a rabbit anti-human ␤5 (clone N/A) polyclonal antibody. Another mouse anti-human ␤1 monoclonal antibody (clone P4C10) was purchased from Life Technologies, Gibco BRL (Gaithersburg, MD). A monoclonal antibody against cytokeratins 8 and 18 (clone IT-Ks20.8) was purchased from BioGenix (San Ramon, CA). The secondary antibodies, CY3-conjugated goat anti-mouse, Cy3-conjugated donkey anti-rat immunoglobulin (Ig)G, and fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG were purchased from Jackson Immunoresearch Laboratories Inc. (West Grove, PA) for indirect immunofluorescence and R-phycoerythrin-conjugated goat anti-mouse IgG (clone A85-1), FITC-conjugated mouse anti-rat IgG (clone RG11/39.4), and FITC-conjugated goat anti-rabbit IgG (clone A85-1) were purchased from BD Pharmingen (San Diego, CA) for flow cytometry.
Indirect Immunofluorescence
Tissues were fixed in 4% paraformaldehyde for 3 hours at 4°C, and then after rinsing 3 times in PBS for 15 minutes, they were stored overnight in 30% sucrose/PBS at 4°C. Tissues were embedded in OCT (Tissue-Tek Optimal Cutting Temperature; Sakura Inc., Torrance, CA) compound and stored at Ϫ80°C until used. Cryosections were cut at 4-m thickness. Primary antibodies were added at the appropriate dilutions and incubated for 60 minutes, followed by 3 washes in PBS. Sections were blocked with PBS containing 2% normal goat or donkey serum for 45 minutes, and then treated for 60 minutes with CY3-conjugated goat anti-mouse IgG for ␣1-5, ␣V, ␤1-4 integrins, and cytokeratin 8 and 18; Cy3-conjugated donkey anti-rat IgG for ␣6; and FITC-conjugated goat antirabbit IgG for ␤5. After 3 washes in PBS, the sections were mounted in Vectashield (Vector Laboratories, Inc., Burlingame, CA) and viewed in an Axioplan2 fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY). Pictures were taken using a CCD camera and the Zeiss image program and were processed using Adobe Photoshop 5.5 software (Adobe Systems, Inc., San Jose, CA). Appropriate control sections were processed as described earlier with the omission of the primary antibody. The intensity of immunostaining was graded on a scale of Ϫ to 3ϩ: Ϫ ϭ negative; 1ϩ ϭ weak staining; 2ϩ ϭ moderate staining; and 3ϩ ϭ strong staining. The evaluation of immunostaining was performed by 2 investigators (K.F. and R.H.W.) without the knowledge of the primary antibodies, and sections obtained from the 5 different specimens were scored for each integrin subunit.
Crypt Isolation and Disaggregation
Crypt isolation and disaggregation were performed by using our methods described previously. 6, 13 Briefly, a 1 ϫ 5-cm piece of normal colonic tissue was incubated for 15 minutes in 0.04% sodium hypochlorite in PBS at room temperature to sterilize the surface. From this point in the procedure, all solutions were sterilized by filtration before use. The colonic tissue was then washed in PBS and incubated in 3 mmol/L ethylenediaminetetraacetic acid (EDTA) plus 0.5 mmol/L dithiothreitol in PBS for 75 minutes at room temperature. After this incubation, the tissue was washed once with PBS, 10 mL of PBS was added, and the tube was shaken vigorously for 15 seconds. This vigorous shaking liberated the crypts from the submucosa. The PBS containing the crypts was transferred to a centrifuge tube, and fresh PBS was added to the colonic tissue. The shaking step was repeated 4 times until the crypt yield diminished. The centrifuge tubes containing the crypt suspension were centrifuged gently (400 rpm for 5 min), the PBS was removed, and the crypts were resuspended gently in PBS. After further gentle centrifugation, the crypts were resuspended in 20 mL of 0.3% pancreatin (grade II, catalog no. P1500; Sigma Chemical Co., St. Louis, MO) in PBS and incubated for 75 minutes at room temperature with occasional shaking. At the end of the incubation period, the cell suspension was diluted with an equal volume of PBS and transferred to centrifuge tubes. The tubes were centrifuged at 1000 rpm for 5 minutes, the supernatant fluid was discarded, and the cell pellet was resuspended in the EDTA/dithiothreitol mixture used to isolate the crypts. The tubes were centrifuged once again and the pellet was resuspended in PBS. A drop of the cell suspension was checked microscopically to confirm that a single cell suspension had been obtained and this was counted by using a hemocytometer. The percentage of viable cells was determined by using trypan blue. This single cell suspension was used for the adhesion assay, flow cytometric analysis and sterile sorting, and colony assay.
Adhesion to Extracellular Matrix Proteins
Twelve-well flat-bottom plates were coated overnight at 4°C with ECM proteins diluted in PBS. Type I collagen (Sigma) was used at 80 g/mL, type IV collagen (Sigma, C-0543) at 25 g/mL, laminin (Sigma, L-2020) at 25 g/mL, and fibronectin (Sigma, F-4759) at 100 g/mL. After washing, the plates coated with ECM proteins were incubated with 0.5 mg/mL of bovine serum albumin at 37°C for 1 hour to prevent nonspecific binding and washed in PBS before use. Five ϫ 10 5 crypt cells were added into each well in 1 mL of William's E medium containing 5% fetal bovine serum (FBS) and incubated at 37°C for 1 hour. Wells were washed 3 times with PBS to remove unbound cells. The attached cells then were removed by trypsin (0.25%)-EDTA (1 mmol/L) digestion for 5 minutes, followed by pipetting, and counted by using a hemocytometer.
Immunofluorescence Labeling and Flow Cytometric Analysis
After the isolation of crypt cells from human colonic tissues, 10 6 cells were suspended in 0.1 mL of PBS containing 2% FBS. A total of 1 g anti-␣ (␣1-6 and ␣V)-or ␤ (␤1-5)-integrin antibody in 20 L of PBS was added to the cells and incubated on ice for 20 minutes. The cells were then washed twice in 1 mL of cold PBS/FBS, and 1 g of phycoerythrin-conjugated goat anti-mouse IgG (for ␣1-5, ␣V, and ␤1-4), FITC-conjugated mouse anti-rat IgG (for ␣6), and FITC-conjugated goat anti-rabbit IgG (for ␤5) was added to the cells for 20 minutes at 4°C. To remove excess phycoerythrin-or FITC-conjugated antibody, the cells were washed twice with 1 mL of PBS/FBS. Control cells were not treated with anti-integrin antibody. Cells were analyzed on a BectonDickinson fluorescence-activated cell sorter (FACS) scan (Becton-Dickinson, Franklin Lakes, NJ). At least 10,000 events were acquired for each sample.
Cell Sorting
To sort the cell populations expressing ␤1-integrin and culture the sorted cells in soft agar, sterile sorting using flow cytometry was performed according to the method of Rosfjord and Dickson. 14 Briefly, after the isolation of crypt cells, the suspension of 5 ϫ 10 6 cells in 0.1 mL of William's medium containing 2% FBS was transferred to a sterile 12-ϫ 75-mm snap-cap tube (Becton-Dickinson). After centrifuging the cells, 1 g of sterile ␤1-integrin antibody in 100 L of cold William's medium was added to the cells. After incubation on ice for 20 minutes with intermittent agitation, the cells were washed twice in PBS/FBS. A total of 1 g of phycoerythrin-conjugated goat anti-mouse IgG was then added to the cells for 20 minutes at 4°C. After rinsing the cells in PBS/FBS twice, 4 mL of William's medium was added to the cells, and the cells with strong expression of ␤1-integrin were sorted into a sterile tube for colony assay.
Colony Assay
The colony assay was performed by using the method described previously. 6 Briefly, an underlay containing an equal mixture of 1.0% agar (Difco, Detroit, MI) and ϫ2 William's medium plus 10% FBS was kept at 40°C until it was used. The conditioned medium from LIM1863 colon cancer cells was used as a positive clonogenic factor and added to appropriate wells. Two milliliters of the mixture was aliquoted into the wells of 6-well tissue culture plates (Nunc, Naperville, IL) in triplicate. The cells were resuspended in a mixture of equal parts of 0.8% agarose (type VII, Sigma) and ϫ2 William's medium plus 10% FBS (kept at 37°C) at a final cell concentration of 5 ϫ 10 4 /mL. Two milliliters of the cell suspension was aliquoted into each well. The plates were allowed to set and incubated for 21 days at 37°C. After the incubation, the plates were examined by using the low-power objective of an inverted microscope, and colonies were confirmed by using a high-power objective. Colonies were defined as aggregates of more than 40 cells. Aggregates of 15-40 cells were scored as clusters. All assays were performed in triplicate.
Statistical Analysis
All statistical analyses were performed by using a 2-factor analysis of variance. A value of P Ͻ 0.05 was deemed significant.
Results
Expression and Distribution of Integrin Subunits Along the Crypts
The expression of the ␣ and ␤ subunits of integrin and their distribution along the crypt was determined by a conventional indirect immunofluorescent technique ( Figure 1A ). The ␣6 subunit was uniformly detected in the crypt as well as at the luminal surface. The ␣5, ␤2, ␤3, and ␤4 subunits also were detected uniformly in the crypt, but not at the luminal surface. Interestingly, in the case of the ␤1 and ␣2 subunits, the cells located at the lower part (one third and two thirds, respectively) of crypts expressed higher levels of ␤1 and ␣2 integrins than the cells at the upper part. In contrast, the expression of ␣3 subunit in the lower part (at the base) of the crypts was much lower than that in the upper part. The expression of the ␣4 and ␤5 subunits in the crypts was very faint, whereas they were strongly expressed in the stromal cells. The results are summarized in Table 1 .
From these results, we observed that the integrin ␤1 subunit was expressed strongly in the lower part (one third) of the crypts, the region that contains the stem cells. To confirm the unique distribution of the ␤1 subunit, another ␤1-integrin antibody purchased from Gibco-BRL also was used. Both of these antibodies showed the same expression pattern of the ␤1-integrin subunit in 2 different serial sections ( Figure 1B ).
FACS Analysis of Integrin Expression of Isolated Colonic Crypt Cells
To confirm the indirect immunofluorescence results, we then analyzed the integrin expression on isolated single crypt cells by using flow cytometry ( Figures  3A and 3B) . The ␤1 and ␣2 integrin subunits showed strong fluorescence intensity as compared with the other subunits with 2 peaks of fluorescence in the single cell population. With the ␤1 integrin antibody the strongly staining peak contained 41% of the cell population and we concluded that the cells in this peak were derived from the bottom portion of the crypt that had stained 
Ϫ ϭ negative; 1ϩ ϭ weak; 2ϩ ϭ moderate; 3ϩ ϭ strong staining. strongly in the immunohistochemistry study ( Figure 2 ). Although FACS analysis of the ␤2-integrin antibody staining also indicated that there were 2 peaks of fluorescence, the height of the peaks indicated that the fluorescent intensity and the percentage of cells positive were both less than that seen for ␤1-integrin ( Figure 3A ).
Adhesion to Extracellular Matrix Proteins
To confirm the function of the expressed integrins by showing adhesion to their known ligands, we conducted adhesion assays by using the crypt single-cell suspension. As shown in Figure 4 , the average recovery of adherent cells was approximately 20%, 6%, 2%, and 8% for collagen type 1, collagen type IV, fibronectin, and laminin, respectively. The preferential adhesion to collagen 1 was not surprising because it has been shown that the ␣2-and ␤1-integrin dimer acts as a collagen type 1 receptor. 7 
Colony Formation From Single Cells After Cell Sorting by Using ␤1 Integrin Antibody
The percentage of viable cells before and after cell sorting was determined by using trypan blue and the mean viability was approximately 88% before sorting and 82% after sorting. The colonies were derived from single cells from human colonic crypts after 21 days of culture in agarose. We confirmed that the cells forming the colony originated from epithelial cells by staining with an antibody to cytokeratin 8 and 18, which is an epithelial marker (results not shown).
The colony assay was performed by using the crypt cells obtained from human surgical specimens. In assessing our cloning assays, both colonies (Ͼ40 cells) and clusters (15-40 cells) were counted. As we described previously, 6 10% LIM1863 conditioned medium was used as a clonogenic factor. Colonies were obtained at very low frequency in control cultures ( Figure 5 ). Five experiments using single cells isolated from different human colons yielded a mean of 2.4 Ϯ 1.1 colonies per plate in triplicate control cultures ( Table 2) .
As expected, the addition of LIM1863 conditioned medium into the soft agar significantly increased the colony count in this assay system (Table 2) . Sorting with ␤1 integrin antibody increased the proportion of clonogenic cells. In a series of 5 experiments, in the cells that were sorted by the ␤1-integrin antibody and cultured in soft agar containing the LIM1863 conditioned medium, colony numbers significantly increased from 5 Ϯ 1.7 (10% LIM1863) to 9.2 Ϯ 2.2 (␤1-integrin ϩ 10% LIM1863) colonies per plate. It should be noted that the cells that were sorted by the ␤1-integrin antibody with or without the addition of LIM1863-conditioned medium produced more colonies than the unsorted cells with or without the conditioned medium in all of 5 assays (Table 2 ). There also were many more clusters in plates using the cells sorted by the ␤1-integrin antibody with or without the LIM1863-conditioned medium.
Discussion
In this study, we found that colonic crypt cells that were capable of forming actively growing colonies in agar could be enriched by using a FACS on the basis of high surface expression of ␤1-integrin. We have shown the use of flow cytometric analysis of a suspension of viable single human colonic crypt cells.
The development of a clonogenic assay for the proliferative cells of the colonic mucosa has been reported 6 and is essential for detailed studies on the biology of the crypt cells, including the identification of specific markers for the stem cells of the crypt. In the hematopoietic system, it was the development of a method of cloning the cells from the bone marrow that led to the discovery of the family of growth and differentiation factors that now are known to control hematopoiesis. We have used our recently described method for obtaining viable single-cell suspensions from colonic crypts isolated from normal colonic mucosa 6 to analyze the expression patterns of various integrins of the crypt cells and to sort them using a flow cytometer. Further, we evaluated the ability of the sorted cells to proliferate in this clonogenic assay.
The simplest definition of intestinal epithelial stem cells is that the cell must be undifferentiated and capable of proliferation and self-maintenance, producing many differentiated progeny, and regenerating the tissue after injury. 2 The body contains self-renewing stem cell systems in many, if not all, tissues, including bone marrow, skin, and testis. 11, 15 Jones and Watt 8 and Jones et al. 9 have shown that keratinocytes with characteristics of stem cells can be isolated from cultured human epidermis on the basis of high surface expression of ␤1-integrin. On the other hand, Li et al. 10 have shown that human keratinocyte stem cells could be isolated by the expression patterns of ␣6-integrin and a monoclonal antibody named 10G7 that has been described as a proliferation-associated cell surface marker. Shinohara et al. 11 have shown that selection of mouse testis cells with anti-␤1-or anti-␣6 -integrin antibody produced cell populations with a significantly enhanced ability to colonize recipient testes and donor cell-derived spermatogenesis in vivo. 11 The stem cells of the colon are believed to lie at or near the base of the crypts of Lieberkuhn. 3, 16 There is one study, however, that showed that the stem cells in the ascending colon in the rat were located in the middle of the crypt. 17 This study has not been repeated in human colonic tissue.
In this study, we investigated the cell surface integrins as candidate markers of stem cells in the colon on the basis that stem cells of different tissues might show certain similarities in biologic behavior and share similar molecular properties. We first determined the distribution pattern of integrin subunits within the colonic mucosa, paying specific attention to the distribution of the integrin subunit along the crypts by using an indirect immunofluorescence technique. As shown in Figure  1A , the immunofluorescence study showed that the cells located in the lower part of the crypts expressed higher levels of ␤1-and ␣2-integrin than the cells in the upper part. Although ␣2-integrin expression was seen from the base to the middle part of the crypt, the expression of ␤1-integrin was identified only on epithelial cells in the lower one third of the crypt. These findings are similar to the distribution of ␣2␤1 integrin in the human small intestine where staining only was found in the lower part of the crypt. 18 There have been few previous studies of the immunolocalization of integrins in the normal colonic epithelium. 19, 20 Our study has confirmed the previous description of the distribution of the ␣2-integrin subunit as being expressed strongly on epithelial cells lining the base of the crypts. However, these studies described the staining pattern of ␤1-integrin subunit as being almost uniform along the crypt. One of the reasons that our results were different from previous studies may be owing to the antibodies used. To confirm the accuracy of the localization of ␤1-integrin along the crypts, we used 2 monoclonal antibodies of ␤1-integrin produced from different clones, which were purchased from 2 different suppliers. We confirmed that both antibodies showed the same staining pattern of ␤1-integrin along the crypts ( Figure 1B ). The ␤1-integrin staining pattern was confirmed by the flow cytometric analysis of the isolated single crypt cells that showed 2 distinct populations of cells based on staining intensity ( Figure 3A) . Estimates of stem cell number in the colonic mucosa vary widely depending on how they are assessed. The best estimate is that there are 4 -6 stem cells per crypt with possibly another 4 -6 daughter cells that can assume stem cell properties if the stem cell is damaged. 2, 3 However, it should be noted that chimeric animal studies have shown that each crypt arises from a singe precursor cell. 21 This discrepancy arises largely because of differences in the operational definition of the stem cells and their ability to change their properties in response to circumstances, including the choice of experimental manipulations. In this study, approximately 40% of the crypt cells were sorted on the basis of high expression of ␤1-integrin ( Figure 2 ) and selection of cells with ␤1-integrin antibody produced a cell population with significantly enhanced ability to form colonies in soft agar (Table 2 ). Even after enrichment of the proliferative cells of the crypt after sorting with ␤1-integrin antibody, the number of colonies formed is much less than the predicted number of stem cells in the sorted population. As discussed previously, 6 this probably indicates that the culture conditions being used are still suboptimal and further studies are needed to identify the growth factors that these cells require for efficient clonogenic growth. Although it remains unclear whether or not the cells forming colonies in the soft agar assay are stem cells, they at least showed an enhanced ability for clonogenic growth, which is a property of stem cells in other systems. We also examined the clonogenic potential for the cells sorted by ␣2-integrin antibody; however, there was no increase in colony number in the sorted population (data not shown). The reason for this might be that the distribution of ␣2-integrin along the crypts extends further up the crypt and is not restricted to the proliferative zone of the crypt and therefore the enrichment for proliferative cells was not as marked. A third integrin, ␤2-integrin, also identified a subpopulation of cells by FACS analysis ( Figure 3A) ; however, both the intensity of staining and the percentage of positive cells was less than for ␤1-integrin. In addition, the histologic distribution of ␤2-integrin staining was not as discrete as that shown by the ␤1-integrin antibody ( Figure 1A) .
In this study we have shown that ␤1-integrin is a surface marker for the cells in the proliferative zone of the human colonic mucosa. The function of this molecule and its role in this tissue are still unknown. Binding of integrins with ECM proteins has been shown to result in activation of a variety of cellular signaling pathways. 22 It is of great interest that Strater et al. 23 recently described that ␤1-integrin/matrix (collagen type I) interaction inhibits the induction of apoptosis in isolated human colonic crypts. Further, accumulating evidence shows overlap between signals generated by integrins and the consensus Ras-signaling pathway triggered by receptor tyrosine kinases that is important in cell proliferation and differentiation. 24, 25 Integrin-mediated cell adhesion also has been shown to activate mitogen-activated protein kinase (MAPK), a key downstream effector of the Ras-signaling pathway. 25 Jones and Watt 8 and Jones et al. 9 have shown recently that human epidermal stem cells can be isolated on the basis of high surface expression of ␤1-integrin, and, further, they have investigated whether high ␤1-integrin expression and adhesiveness to ECM proteins are essential for maintaining keratinocytes in the stem cell compartment. 26 They introduced a dominant-negative ␤1-integrin mutant, CD8␤1, into cultured human keratinocytes, thereby interfering with ␤1-integrin function. As a result, they observed that adhesiveness and MAPK activation were inhibited, and that exit from the stem cell compartment was stimulated. Their results suggest that ␤1-integrin and MAPK may cooperate to maintain the epidermal stem cell compartment in vitro. Further studies are needed to clarify the interaction of ␤1-integrin and MAPK activity in colonic stem cells.
In summary, we have used an in vitro culture system for clonal growth from a single cell suspension to identify ␤1-integrin as a candidate surface marker on the clonogenic cells of the colonic crypt. We cannot as yet identify these clonogenic cells as stem cells for the colonic mu-cosa. Numerous researchers working in the field of stem cell biology have defined stem cells in different ways. 12 A minimalist definition is that stem cells have the capacity for autonomous growth and are capable of both selfrenewal and generation of differentiated progeny. The most studied stem cell populations to date are the hematopoietic stem cells. These stem cells and their pluripotent daughter cells were first identified by using a clonogenic assay similar to that used in this study. More recently, these hematopoietic stem cells have been isolated by using antibodies to cell surface antigens, 4 and their functional properties have been established by transplantation into lethally irradiated host animals under conditions in which the progeny of a single stem cell can be identified. To confirm whether the subpopulation of human colonic crypt cells isolated on the basis of ␤1-integrin expression possess the properties of selfrenewal and differentiation in addition to their ability to form colonies in the clonogenic assay, a novel in vivo transplantation system will have to be developed.
